Nu Skin Enterprises (NYSE:NUS) PT Lowered to $12.50 at DA Davidson

Nu Skin Enterprises (NYSE:NUS) had its target price cut by stock analysts at DA Davidson from $15.50 to $12.50 in a research report issued on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. DA Davidson’s target price indicates a potential upside of 0.16% from the company’s current price.

Separately, StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. Four analysts have rated the stock with a hold rating, According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $20.83.

Nu Skin Enterprises Stock Up 0.5 %

Shares of NUS traded up $0.06 during midday trading on Thursday, hitting $12.48. 180,761 shares of the company’s stock traded hands, compared to its average volume of 723,215. Nu Skin Enterprises has a 1 year low of $11.73 and a 1 year high of $38.23. The firm’s fifty day moving average is $12.66 and its 200-day moving average is $15.89. The company has a current ratio of 2.13, a quick ratio of 1.28 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $616.76 million, a price-to-earnings ratio of 69.00 and a beta of 1.13.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Wednesday, May 8th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.04. The company had revenue of $417.31 million for the quarter, compared to the consensus estimate of $426.55 million. Nu Skin Enterprises had a net margin of 0.44% and a return on equity of 10.73%. Nu Skin Enterprises’s quarterly revenue was down 13.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.37 EPS. As a group, sell-side analysts anticipate that Nu Skin Enterprises will post 1.13 earnings per share for the current year.

Hedge Funds Weigh In On Nu Skin Enterprises

A number of large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of Nu Skin Enterprises by 0.9% during the third quarter. Vanguard Group Inc. now owns 6,235,495 shares of the company’s stock worth $132,255,000 after purchasing an additional 53,638 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Nu Skin Enterprises by 91.8% during the third quarter. Invesco Ltd. now owns 1,694,112 shares of the company’s stock valued at $35,932,000 after acquiring an additional 810,778 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Nu Skin Enterprises by 17.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,157,697 shares of the company’s stock valued at $22,482,000 after acquiring an additional 173,193 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Nu Skin Enterprises by 6.6% in the third quarter. Bank of New York Mellon Corp now owns 767,442 shares of the company’s stock worth $16,277,000 after acquiring an additional 47,847 shares during the last quarter. Finally, ProShare Advisors LLC boosted its stake in shares of Nu Skin Enterprises by 36.5% in the first quarter. ProShare Advisors LLC now owns 597,614 shares of the company’s stock worth $8,265,000 after acquiring an additional 159,831 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors and hedge funds.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.